COVID-19 Vaccine Acceptance in the Democratic Republic of Congo: A Cross-Sectional Survey
Top Cited Papers
Open Access
- 14 February 2021
- Vol. 9 (2), 153
- https://doi.org/10.3390/vaccines9020153
Abstract
We investigated the level of willingness for COVID-19 vaccination in the Democratic Republic of Congo (DRC). Data were collected between 24 August 2020 and 8 September 2020 through an online survey. A total of 4131 responses were included; mean age of respondents was 35 years (standard deviation: 11.5); 68.4% were females; 71% had elementary or secondary school education. One fourth (24.1%) were convinced that COVID-19 did not exist. Overall, 2310 (55.9%) indicated they were willing to be vaccinated. In a multivariable regression model, belonging to the middle and high-income category (OR = 1.85, CI: 1.46–2.35 and OR = 2.91, CI: 2.15–3.93, respectively), being tested for COVID-19 (OR = 4.71, CI: 3.62–6.12; p < 0.001), COVID-19 community vaccine acceptance (OR = 14.45, CI: 2.91–71.65; p = 0.001) and acknowledging the existence of COVID-19 (OR = 6.04, CI: 4.42–8.23; p < 0.001) were associated with an increased willingness to be vaccinated. Being a healthcare worker was associated with a decreased willingness for vaccination (OR = 0.46, CI: 0.36–0.58; p < 0.001). In conclusion, the current willingness for COVID-19 vaccination among citizens of the DRC is too low to dramatically decrease community transmission. Of great concern is the low intention of immunization among healthcare workers. A large sensitization campaign will be needed to increase COVID-19 vaccine acceptance.Keywords
This publication has 22 references indexed in Scilit:
- Factors associated with adherence to COVID-19 prevention measures in the Democratic Republic of the Congo (DRC): results of an online surveyBMJ Open, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesNew England Journal of Medicine, 2020
- Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialThe Lancet, 2020
- COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune ResponseVaccines, 2020
- Impact of the COVID-19 pandemic on psychosocial health and well-being in South-Asian (World Psychiatric Association zone 16) countries: A systematic and advocacy review from the Indian Psychiatric SocietyIndian Journal of Psychiatry, 2020
- Therapeutic management of patients with COVID-19: a systematic reviewInfection Prevention in Practice, 2020
- The role of masks and respirator protection against SARS-CoV-2Infection Control & Hospital Epidemiology, 2020
- Social Distancing and Transmission-reducing Practices during the 2019 Coronavirus Disease and 2015 Middle East Respiratory Syndrome Coronavirus Outbreaks in KoreaJournal of Korean Medical Science, 2020
- Social Distancing against COVID-19: Implication for the Control of InfluenzaJournal of Korean Medical Science, 2020